National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

synthetic peptide-based erythropoiesis stimulating agent
A synthetic, non-recombinant, pegylated, peptidic erythropoiesis stimulating agent. Synthetic peptide-based erythropoiesis stimulating agent binds to and activates the erythropoietin (EPO) receptor on erythroid progenitor cells, thereby inducing their proliferation and differentiation into mature erythrocytes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Hematide



Previous:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine, synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine, synthetic human corticotropin-releasing factor, synthetic human papillomavirus 16 E6 peptide, synthetic melanoma-associated antigens vaccine
Next:synthetic peptides E-PRA and E-PSM vaccine, Synthoestrin, Synthroid, T-Phyl, T138067 sodium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov